| |
| |
|
| Insider
Information: |
Public Joint Stock Co Pharmstandard |
| Relationship: |
10% Owner |
| City: |
Dolgoprudny |
| State: |
1Z |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,165,344 |
|
|
Indirect Shares
|
13,142,784 |
|
|
| Direct
Value |
$3,775,715 |
|
|
|
Indirect Value
|
$703,796 |
|
|
| Total
Shares |
14,308,128 |
|
|
| Total
Value |
$4,479,511 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Argos Therapeutics Inc |
ARGS |
10% Owner |
2014-02-12 |
0 |
2017-10-31 |
13,142,784 |
Premium* |
|
|
Protara Therapeutics, Inc |
TARA |
10% Owner |
2014-10-27 |
1,165,344 |
2014-10-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARGS |
Argos Therapeutics Inc |
10% Owner |
– – • |
2017-10-31 |
4 |
D |
$795.96 |
$79,194,040 |
I/I |
(99,495) |
13,142,784 |
0 |
- |
|
| ARGS |
Argos Therapeutics Inc |
10% Owner |
– – • |
2016-10-07 |
4 |
B |
$4.73 |
$99,330 |
I/I |
21,000 |
13,242,279 |
1.5 |
- |
|
| ARGS |
Argos Therapeutics Inc |
10% Owner |
– – • |
2016-10-06 |
4 |
B |
$4.81 |
$12,698 |
I/I |
2,640 |
13,221,279 |
1.5 |
- |
|
| ARGS |
Argos Therapeutics Inc |
10% Owner |
– – • |
2016-10-05 |
4 |
B |
$4.85 |
$4,365 |
I/I |
900 |
13,218,639 |
1.42 |
- |
|
| ARGS |
Argos Therapeutics Inc |
10% Owner |
– – • |
2016-10-04 |
4 |
B |
$4.69 |
$33,599 |
I/I |
7,164 |
13,217,739 |
1.5 |
- |
|
| ARGS |
Argos Therapeutics Inc |
10% Owner |
– – • |
2016-10-03 |
4 |
B |
$4.70 |
$53,148 |
I/I |
11,308 |
13,210,875 |
1.5 |
- |
|
| ARGS |
Argos Therapeutics Inc |
10% Owner |
– – • |
2016-09-30 |
4 |
B |
$4.71 |
$142,393 |
I/I |
30,232 |
13,199,567 |
1.5 |
- |
|
| ARGS |
Argos Therapeutics Inc |
10% Owner |
– – • |
2016-09-29 |
4 |
B |
$4.60 |
$69,460 |
I/I |
15,100 |
13,169,335 |
1.5 |
- |
|
| ARGS |
Argos Therapeutics Inc |
10% Owner |
– – • |
2016-09-28 |
4 |
B |
$4.54 |
$129,472 |
I/I |
28,518 |
13,154,235 |
1.5 |
- |
|
| ARGS |
Argos Therapeutics Inc |
10% Owner |
– – • |
2016-09-20 |
4 |
B |
$4.77 |
$196,805 |
I/I |
41,259 |
13,125,717 |
1.5 |
- |
|
| ARGS |
Argos Therapeutics Inc |
10% Owner |
– – • |
2016-09-19 |
4 |
B |
$4.76 |
$26,561 |
I/I |
5,580 |
13,084,458 |
1.5 |
- |
|
| ARGS |
Argos Therapeutics Inc |
10% Owner |
– – • |
2016-09-16 |
4 |
B |
$4.78 |
$175,101 |
I/I |
36,632 |
13,078,578 |
1.5 |
- |
|
| ARGS |
Argos Therapeutics Inc |
10% Owner |
– – • |
2016-09-15 |
4 |
B |
$4.76 |
$75,589 |
I/I |
15,880 |
13,041,946 |
1.5 |
- |
|
| ARGS |
Argos Therapeutics Inc |
10% Owner |
– – • |
2016-09-01 |
4 |
B |
$4.78 |
$81,150 |
I/I |
16,977 |
13,026,066 |
1.5 |
- |
|
| ARGS |
Argos Therapeutics Inc |
10% Owner |
– – • |
2016-08-24 |
4 |
B |
$4.57 |
$252,374 |
I/I |
55,224 |
13,009,089 |
1.5 |
- |
|
| ARGS |
Argos Therapeutics Inc |
10% Owner |
– – • |
2016-08-24 |
4 |
B |
$4.55 |
$262,863 |
I/I |
57,772 |
12,953,865 |
1.5 |
- |
|
| ARGS |
Argos Therapeutics Inc |
10% Owner |
– – • |
2016-08-23 |
4 |
B |
$4.36 |
$41,852 |
I/I |
9,599 |
12,896,093 |
1.5 |
- |
|
| ARGS |
Argos Therapeutics Inc |
10% Owner |
– – • |
2016-08-22 |
4 |
B |
$4.26 |
$93,507 |
I/I |
21,950 |
12,886,494 |
1.5 |
- |
|
| ARGS |
Argos Therapeutics Inc |
10% Owner |
– – • |
2016-08-19 |
4 |
B |
$4.23 |
$226,407 |
I/I |
53,524 |
12,864,544 |
1.5 |
- |
|
| ARGS |
Argos Therapeutics Inc |
10% Owner |
– – • |
2016-08-02 |
4 |
B |
$0.00 |
$0 |
I/I |
2,363,636 |
12,811,020 |
1.42 |
- |
|
| ARGS |
Argos Therapeutics Inc |
10% Owner |
– – • |
2016-06-29 |
4 |
B |
$0.00 |
$0 |
I/I |
2,678,301 |
10,447,384 |
1.42 |
- |
|
| ARGS |
Argos Therapeutics Inc |
10% Owner |
– – • |
2016-03-14 |
4 |
B |
$0.00 |
$0 |
I/I |
1,785,534 |
7,769,083 |
1.42 |
- |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2014-10-27 |
4 |
A |
$0.00 |
$0 |
D/D |
565,344 |
1,165,344 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2014-10-27 |
4 |
B |
$10.00 |
$6,000,000 |
D/D |
600,000 |
600,000 |
2.45 |
- |
|
| ARGS |
Argos Therapeutics Inc |
10% Owner |
– – • |
2014-02-12 |
4 |
B |
$8.00 |
$10,200,000 |
I/I |
1,275,000 |
5,983,549 |
1.5 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
